Abstract
The in vitro and in vivo antimicrobial activity of sporaricin A, a new aminoglycoside, was compared with that of amikacin, dibekacin, and gentamicin. Sporaricin A showed a broad spectrum of activity against various gram-positive and -negative bacteria, including amikacin-, dibekacin-, or gentamicin-resistant strains. Sporaricin A inhibited more than 90% of clinical isolates of staphylococci, Klebsiella, Enterobacter, Citrobacter, Serratia, and Proteus, except for P. morganii and P. inconstans, at the concentration of 3.13 microgram/ml. This activity, except for that against Serratia, was similar to that of amikacin. Against P. inconstans and S. marcescens, sporaricin A was more effective than amikacin, dibekacin, and gentamicin. However, its activity against Pseudomonas aeruginosa was relatively weak in comparison with three other aminoglycosides. Sporaricin A was highly effective against bacteria that had various aminoglycoside-inactivating enzymes and that were resistant to the other drugs tested, but it was not active against those with aminoglycoside 3-acetyltransferase-I. The activity of sporaricin A tended to be greater with a reduction in inoculum size of bacteria and an increase in medium pH and decreased slightly in the presence of 10 to 50% horse serum. The in vitro activity was confirmed by in vivo tests in experimental infections with various bacteria. Its protective effect seemed to be equal to or greater than that of amikacin or dibekacin.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Deushi T., Iwasaki A., Kamiya K., Kunieda T., Mizoguchi T., Nakayama M., Itoh H., Mori T., Oda T. A new broad-spectrum aminoglycoside antibiotic complex, sporaricin. I. Fermentation, isolation and characterization. J Antibiot (Tokyo) 1979 Mar;32(3):173–179. doi: 10.7164/antibiotics.32.173. [DOI] [PubMed] [Google Scholar]
- Deushi T., Nakayama M., Watanabe I., Mori T. A new broad-spectrum aminoglycoside antibiotic complex, sporaricin. III. The structures of sporaricins A and B. J Antibiot (Tokyo) 1979 Mar;32(3):187–192. doi: 10.7164/antibiotics.32.187. [DOI] [PubMed] [Google Scholar]
- Egan R. S., Stanaszek R. S., Cirovic M., Mueller S. L., Tadanier J., Martin J. R., Collum P., Goldstein A. W., De Vault R. L., Sinclair A. C. Fortimicins A and B, new aminoglycoside antibiotics. III. Structural identification. J Antibiot (Tokyo) 1977 Jul;30(7):552–563. doi: 10.7164/antibiotics.30.552. [DOI] [PubMed] [Google Scholar]
- Iwasaki A., Itoh H., Mori T. A new broad-spectrum aminoglycoside antibiotic complex, sporaricin. II. Taxonomic studies on the sporaricin producing strain Saccharopolyspora hirsuta subsp. Kobensis nov. subsp. J Antibiot (Tokyo) 1979 Mar;32(3):180–186. doi: 10.7164/antibiotics.32.180. [DOI] [PubMed] [Google Scholar]
- Kobayashi F., Yamaguchi M., Mitsuhashi S. Phosphorylated inactivation of aminoglycosidic antibiotics by Pseudomonas aeruginosa. Jpn J Microbiol. 1971 May;15(3):265–272. doi: 10.1111/j.1348-0421.1971.tb00578.x. [DOI] [PubMed] [Google Scholar]
- Nara T., Yamamoto M., Kawamoto I., Takayama K., Okachi R., Takasawa S., Sato T., Sato S. Fortimicins A and B, new aminoglycoside antibiotics. I. Producing organism, fermentation and biological properties of fortimicins. J Antibiot (Tokyo) 1977 Jul;30(7):533–540. doi: 10.7164/antibiotics.30.533. [DOI] [PubMed] [Google Scholar]
- Sato S., Iida T., Okachi R., Shirahata K., Nara T. Enzymatic acetylation of fortimicin A and seldomycin factor 5 by aminoglycoside 3-acetyltransferase I: [AAC(3)-I] of E. coli KY8348. J Antibiot (Tokyo) 1977 Nov;30(11):1025–1027. doi: 10.7164/antibiotics.30.1025. [DOI] [PubMed] [Google Scholar]
- Wilfert J. N., Barrett F. F., Ewing W. H., Finland M., Kass E. H. Serratia marcescens: biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital. Appl Microbiol. 1970 Feb;19(2):345–352. doi: 10.1128/am.19.2.345-352.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]